- Report
- July 2023
- 117 Pages
Global
From €6620EUR$7,500USD£5,707GBP
- Report
- April 2023
- 121 Pages
Global
From €3487EUR$3,950USD£3,006GBP
- Report
- April 2023
- 140 Pages
Global
From €8386EUR$9,500USD£7,228GBP
- Report
- April 2023
- 82 Pages
Global
From €3487EUR$3,950USD£3,006GBP
- Report
- April 2023
- 164 Pages
Global
From €8386EUR$9,500USD£7,228GBP
- Report
- April 2023
- 120 Pages
Global
From €6620EUR$7,500USD£5,707GBP
- Report
- April 2023
- 161 Pages
Global
From €6620EUR$7,500USD£5,707GBP
- Report
- April 2023
- 224 Pages
Global
From €6620EUR$7,500USD£5,707GBP
- Report
- March 2023
- 30 Pages
Global
From €2869EUR$3,250USD£2,473GBP
- Report
- March 2023
- 30 Pages
Global
From €2869EUR$3,250USD£2,473GBP
- Report
- March 2023
- 30 Pages
Global
From €2869EUR$3,250USD£2,473GBP
- Report
- February 2023
- 30 Pages
Japan
From €2427EUR$2,750USD£2,092GBP
- Report
- February 2023
- 30 Pages
Global
From €2427EUR$2,750USD£2,092GBP
- Report
- February 2023
- 220 Pages
Global
From €6620EUR$7,500USD£5,707GBP
- Report
- February 2023
- 30 Pages
Global
From €2427EUR$2,750USD£2,092GBP
- Report
- February 2023
- 30 Pages
Global
From €2427EUR$2,750USD£2,092GBP
- Report
- February 2023
- 94 Pages
Global
From €3487EUR$3,950USD£3,006GBP
- Report
- February 2023
- 97 Pages
Global
From €4193EUR$4,750USD£3,614GBP
- Report
- February 2023
- 195 Pages
Global
From €8386EUR$9,500USD£7,228GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2427EUR$2,750USD£2,092GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more